Colleagues: Read on for the latest news and events, and keep up to date on all things DoM via Twitter, Facebook, and our website.

The Chair's Notes

I am very pleased to announce that Drs. Steven Asch and Sang-ick Chang have agreed to assume leadership of the Division of General Medical Disciplines (DGMD) in the Department of Medicine, effective Monday June 15th, 2015. Dr. Mark Cullen, the outgoing Chief, is taking on new University leadership responsibilities as the inaugural Director of Population Health Sciences. DGMD is at the foundation of our tripartite mission in the Department. On the clinical front, it includes primary care, family medicine, hospital medicine, geriatrics, palliative care, occupational health, global health and many other important activities. DGMD faculty provide leadership for a large proportion of graduate and undergraduate medical education throughout the School of Medicine. The clinical and population health researchers in the Division are at the forefront of the applied discovery activities that learning health care systems like ours depend upon. Because of this diversity of activities and the 150+ faculty, we have decided to have two senior faculty to lead this Division into the future.

Dr. Sang-ick Chang has been with the Division for 3 years and has led the division’s recent growth of both clinical faculty and practice locations in the outpatient arena. He has enormous experience as a family medicine clinician and clinical operations leader. He will be primarily responsible for leading the clinical activities of the Division. We are proud that for the first time, a clinician-educator will share leadership of one of the Divisions of our Department – a first for Stanford. Dr. Steven Asch has been with the Division for 4 years. He is an internationally known expert in health services research with more than 300 publications and has led the general medicine research activities both on Stanford campus and at the VA, where he will continue to direct the Center for Innovation to Implementation (Ci2i). He will oversee the continued expansion of the implementation science, epidemiology, health services and other research activities of the Division. Both Co-Chiefs will oversee the educational mission. Together, they have the right skills and experiences to lead the Division and to participate in the overall leadership of the department. They make an excellent team!

We are fortunate in the Department of Medicine to have such a deep and broad faculty in DGMD. Drs. Asch and Chang are the right leaders for this time of growth and we look forward to working with them both. Please join me in welcoming them to their new leadership roles.

Robert Harrington, M.D.
Department of Medicine

Our Latest News

Postdoctoral researcher Junaid Zaman receives inaugural UK-US Fulbright British Heart Foundation Research Scholar Award. »

Some heartburn drugs could hurt heart. »

Discovery of molecular pathway could lead to pancreatitis treatments. »

In the latest installment of Research Corner, Ken Mahaffey sat down with Glenn Chertow to discuss clinical research activities in the Division of Nephrology. »

Higher concentration of physicians groups could increase medical costs, researchers say. »

Stanford-India health partnership grows. »

5 Questions: A three-month checkup of MyHeart Counts. »

How Stanford medicine will "develop, define and lead the field of precision health." . »

Why become a doctor? A personal story from oncologist Pelin Cinar. »

Upcoming Events

// Grand Rounds

June 17.
June 24.
July 1.

// Department-Wide

GI Research Conference

Infectious Diseases Lecture Series

Hematology/BMT Tuesday Seminars

Hematology/BMT Wednesday Didactic Seminar

Digestive Diseases Clinical Conference

Fellows Didactic Lecture

Announcements »

In the News

"Federal panel backs approval of new drug to fight hear attacks" - An expert group recommended that the FDA approve a powerful new drug to lower cholesterol and protect against heart attacks. Joshua Knowles provides comment.

New York Times

"'Jonas Salk: A Life,' by Charlotte DeCroes Jacobs" - The New York Times highlights a new biography by Charlotte DeCroes Jacobs about the life and career of Jonas Salk.

New York Times

"The buttered coffee lifestyle" - Christopher Gardner is quoted in this article about the health claims of bulletproof coffee.

Bloomberg BusinessWeek

"Irreproducible biology research costs put at $28 billion per year" - John Ioannidis discusses a study that showed irreproducible biomedical research costs $28B annually.

Nature News

"Exercise, not pills, is the best remedy for aging" - Mehrdad Ayati writes about the importance of exercise for the elderly.

Palm Beach Post

"Controversial mandatory vaccine bill easily clears California Assembly committee" - The Assembly Health Committee passed SB277 Tuesday night. Catherine Forest testified before the committee and is quoted here.

Contra Costa Times

Additional Coverage:
KQED: "Bill that would end ‘Personal Belief Exemption’ advances"

Facebook Twitter DoM Website

View in browser | Contact Us | Unsubscribe